Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

Oracle Chairman Larry Ellison highlighted AI's potential to revolutionize healthcare with early cancer detection and personalized vaccines. President Donald Trump announced a $500 billion private ...

MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer vaccines.

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early ...

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer. We’ve all heard such blusterous aspirational hype before, to be sure ...

You can make that vaccine, that mRNA vaccine, you can make that robotically, again using AI, in about 48 hours." In the early hours as president, Trump nullified Biden-era executive orders ...

Oracle Chairman Larry Ellison highlighted the potential medical benefits of the investment, stating that AI could be used to detect cancers and customize mRNA vaccines to treat them within 48 hours.

Oracle founder Larry Ellison said ... "And you can make that vaccine, that mRNA vaccine, you can make that robotically again using AI in about 48 hours." US CEOS HAVE ‘NOTHING BUT HOPE ...

Oracle, driven by AI and cloud, projects a 15% stock price CAGR potential over five years, and a fair valuation amid a ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 hours.